posted on 2021-04-27, 16:33authored byUylissa A. Rodriguez, Mairobys Socorro, Angela Criscimanna, Christina P. Martins, Nada Mohamed, Jing Hu, Krishna Prasadan, George K. Gittes, Farzad Esni
In contrast to the skin
and the gut, where somatic stem cells and their niche are well characterized, a
definitive pancreatic multipotent cell population in the adult pancreas has yet
to be revealed. Of particular interest is whether such cells may be endogenous
in diabetic patients, and if so, can they be used for therapeutic purposes. In
the current study, we used two separate reporter lines to target Cre-recombinase
expression to the Lgr5 or glucagon expressing cells in the pancreas. We provide
evidence for the existence of a population of cells within and in the proximity
of the ducts that transiently express the stem cell marker Lgr5 during late
gestational stages. Careful timing of tamoxifen treatment in Lgr5EGFP-IRES-CreERT2;R26Tomato
mice allowed us to show that these Lgr5-expressing progenitor cells can
differentiate into α-cells during pregnancy. Furthermore, we report on a spontaneous
α-to β-cell lineage conversion specifically after parturition. The contribution
of Lgr5-progeny to the β-cell compartment through an α-cell intermediate phase early
on after pregnancy appears to be part of a novel mechanism that would counterbalance
against excessive β-cell mass reduction during β-cell involution.
Funding
Supported by NIH/NIDDK grants R01DK101413 (to F.E.) and R01DK120698 (to GKG and F.E.), NCI grant CA236965 (to J.H and F.E), RAC (to F.E) and The Children’s Hospital of Pittsburgh of UPMC (to F.E.).